Uniform Medication Rules Now in Effect
Effective January 1, 2014, The Pennsylvania Horse Racing Commission in accordance with its existing therapeutic regulations (58 Pa. Code 163.304) incorporates and adopts the most current list of therapeutic substances and threshold levels issued by the Racing Medication & Testing Consortium (RMTC) and any subsequent modification approved by The Association of Racing Commissioners International (ARCI) regarding therapeutic medications.
The following chart details these new accepted medication standards and withdrawal times:
Substance | Restricted Administration Time | Threshold | Route of Administration | Experimental Administration Dosage |
---|---|---|---|---|
Acepromazine | 48 Hours | HEPS - 10 ng/mL of urine | Intravenous | 0.05 mg/kg |
Betamethasone | 7 Days | 10 pg/mL in plasma or serum | Intra-articular | 9 mg total in one articular space |
Butorphanol | 48 Hours | Free butorphanol - 2 ng/mL of plasma or Total butorphanol - 300 ng/mL of urine | Intravenous | 0.1 mg/kg |
Clenbuterol | 14 Days | 140 pg/mL of urine or LOD in plasma | Oral | 0.8 mcg/kg |
Dantrolene | 48 Hours | 5-OH dantrolene - 0.1 ng/mL of plasma or serum | Oral | 500 mg total dose |
Detomidine | 72 Hours | 1 ng/mL of carboxydetomidine in urine; LOD for detomidine in plasma | Sublingual detomidine (Domosedan gel) | 40 mcg/kg |
Dexamethasone | 72 Hours | 5 pg/mL of plasma or serum | Oral, Intravenous, IM | 0.05 mg/kg |
Diclofenac | 48 Hours | 5 ng/mL of plasma or serum | Topical | 5” ribbon of Surpass every 12 hours to one site |
DMSO | 48 Hours | 10 mcg/mL of plasma or serum | Oral or IV | |
Firocoxib | 14 Days | 20 ng/mL of plasma or serum | Oral | 0.1 mg/kg for 4 days |
Flunixin | 24 Hours | 20 ng/mL of plasma or serum | Intravenous | 1.1 mg/kg |
Furosemide | 4 Hours | 100 ng/mL in blood and urine specific gravity < 1.010 | Intravenous | Up to 500 mg total dose |
Glycopyrrolate | 48 Hours | 3 pg/mL of plasma or serum | Intravenous | 1 mg total dose |
Ketoprofen | 24 Hours | 10 ng/mL of plasma or serum | Intravenous | 2.2 mg/kg |
Lidocaine (interim) | 72 Hours | 20 pg/mL of total 3OH-lidocaine in plasma | Subcutaneous - distal limb | 200 mg of lidocaine hydrochloride salt |
Mepivacaine | 72 Hours | 3OH-mepivacaine - 10 ng/mL in urine or mepivacaine at LOD in plasma | Subcutaneous - distal limb | 0.07 mg/kg |
Methocarbamol | 48 Hours | 1 ng/mL of plasma or serum | IV or Oral | 15 mg/kg IV, 5 g oral |
Methylprednisone | 7 Days | 100 pg/mL in plasma or serum | Intra-articular | 100 mg total in one article space |
Omeprazole | 24 Hours | omeprazole sulfide - 1 ng/mL in urine | Oral | 3.9 mg/kg |
Phenylbutazone | 24 Hours | 2 mcg/mL of plasma or serum | Intravenous | 4 mg/kg |
Prednisolone | 48 Hours | 1 ng/mL of plasma or serum | Oral | 1 mg/kg |
Procaine Penicillin | Time of Entry | 25 ng/mL of plasma | Intra-muscular | |
Triamcinolone Acetonide | 7 Days | 100 pg/mL of plasma or serum | Intra-articular | 9 mg total in one articular space |
Xylazine (interim) | 48 Hours | 0.01 ng/mL of plasma | Intravenous |